Research Archives

A possible hidden reason for ventilator-associated pneumoniaBy: Jan Jarvis Surgical patients who need ventilators to breathe face heightened risks for pneumonia, but detecting the bacteria that might be causing the infection can be complicated. One reason for the confusion is that bacteria that appear on cultures of the lungs, often labeled “normal respiratory tract flora,” are considered harmless. But they’re Read More »

Dec 19, 2018

Study: Progesterone protects the brain during strokeBy Jan Jarvis HSC Insider Learn more about UNTHSC’s people and programs by signing up for the weekly HSC Insider email. Time is critical when someone has a stroke – especially the first three to four hours. That’s how long someone has to get to the hospital for treatment with the only clot-busting drug Read More »

Nov 19, 2018

A glaucoma treatment that skips the poke in the eyeBy Jan Jarvis One of the ways researchers are exploring treating the optic nerve damage of glaucoma is an injection directly into the eye. But Suchismita Acharya, PhD, is studying a different approach that not only takes the pain out of treating this blinding disease but also holds the promise of curing it. HSC Read More »

Nov 12, 2018

UNTHSC establishes new Institute for Translational ResearchBy Jan Jarvis It often takes many months and thousands of dollars for patients worried about memory loss to find out if they have Alzheimer’s disease. The goal of UNT Health Science Center’s new Institute for Translational Research is to reduce that timeline, giving patients access to therapeutics and diagnostics faster than ever before. Read More »

Nov 6, 2018

Team studying rare disorder discovers novel way to target melanomaBy Jan Jarvis While studying a rare genetic disorder called NGLY1 deficiency, UNT Health Science Center researchers discovered a new targeted treatment for combating melanoma, a skin cancer that kills about 9,000 people in the United States each year. Their research was recently published in the British Journal of Cancer. The discovery came when Read More »

Nov 5, 2018

UNTHSC gets $1.5 million to study possible glaucoma treatmentBy Jan Jarvis First, Gulab Zode, PhD, and his team of researchers discovered how a gene that causes glaucoma leads to the pathology in the eye. Then they found a drug to treat and cure a rare form of the blinding eye disease. Now that same drug could one day be used to treat open angle Read More »

Nov 1, 2018

Scientist says to slow aging, choose exerciseBy Jan Jarvis Regular exercise slows the effects of aging. But the news is less positive for antioxidant supplements, another popular intervention often adopted by health conscious adults. The positive effects of vitamins E and C are not clear, said Nathalie Sumien, Ph.D., Associate Professor, Department of Pharmacology and Neuroscience, Institute for Healthy Aging. Read More »

Oct 25, 2018

UNTHSC splits $2.2 million cancer disparities grantBy Alex Branch A new collaboration between UNT Health Science Center and Langston University seeks to reduce cancer health disparities and prepare minority scholars to perform ground-breaking medical research. UNTHSC and Langston, a historically black college in Oklahoma, recently celebrated the awarding of a $2.2 million grant by the National Cancer Institute. The institutions Read More »

Oct 22, 2018

Promising treatment for disease that destroys eye tissueBy Jan Jarvis Ocular inflammation uveitis is a serious disease that can destroy eye tissue and cause irreversible blindness. Fortunately, blindness and eye damage can be prevented by suppressing the immune system and treating the disease with corticosteroids, said Sai Chavala, MD, Professor of Pharmacology and Neuroscience and Director of Translational Research at the Read More »

Oct 9, 2018

First semester of college represents ‘red zone’ for student drinkingBy Sally Crocker What happens in the first semester of college can profoundly impact students’ alcohol use and future drinking behaviors, especially during the first six weeks, says UNTHSC Associate Professor Dana M. Litt, PhD. Dr. Litt is leading a new study on ways to reach freshmen when they are most impressionable. The three-year project Read More »

Oct 9, 2018